Riley Mccormack serves as Executive at ARCA biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Riley Mccormack has executed 15 insider transactions totaling $3.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 15, 2023 involved receiving (via award) 1,309 shares valued at $29.3K.
Riley Mccormack currently holds 46,499 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Riley Mccormack has been a net buyer of ABIO stock. They have purchased $2.4M and sold $771.0K worth of shares.
Riley Mccormack's most recent insider trade was on Feb 15, 2023, when they sold 1,309 shares at $22.37 per share.
Get notified when new Form 4 filings are submitted
| $25.23 |
| Discretionary |
| Mar 9, 2022 | DMRC | $20.6K | Purchase | 801 | $25.71 | Discretionary |
| Mar 8, 2022 | DMRC | $439.2K | Purchase | 18,347 | $23.94 | Discretionary |
| Mar 8, 2022 | DMRC | $40.5K | Purchase | 1,653 | $24.53 | Discretionary |
| Apr 12, 2021 | DMRC | $0 | Award | 8,644 | $N/A | Discretionary |
| Apr 12, 2021 | DMRC | $0 | Award | 8,644 | $N/A | Discretionary |
| Oct 27, 2020 | DMRC | $0 | Award | 6,546 | $N/A | Discretionary |
| Jan 16, 2015 | ABIO | $75.0K | Sale | 100,000 | $0.75 | Discretionary |
| Jan 15, 2015 | ABIO | $93.8K | Sale | 125,000 | $0.75 | Discretionary |
| Jan 14, 2015 | ABIO | $98.8K | Sale | 125,000 | $0.79 | Discretionary |
| Jan 7, 2015 | ABIO | $174.0K | Sale | 200,000 | $0.87 | Discretionary |
| Jan 6, 2015 | ABIO | $184.0K | Sale | 200,000 | $0.92 | Discretionary |
| Jan 5, 2015 | ABIO | $145.5K | Sale | 150,000 | $0.97 | Discretionary |
| Feb 4, 2014 | ABIO | $1.7M | Purchase | 1,000,000 | $1.70 | Discretionary |